News
The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.
The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver ...
The FDA said yesterday that it is investigating the deaths from liver failure of two non-ambulatory boys with Duchenne ...
Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results